You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abscopal activity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor

Recruiting
  • Bystander Effect
  • +3 more
  • SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
  • Klagenfurt, Kaernten, Austria
    KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma Trial in Darmstadt, MIlan, Pavia (Carbon Ion

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Carbon Ion Therapy
  • Immunotherapy (Pembrolizumab)
  • Darmstadt, Germany
  • +3 more
Feb 11, 2022

Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)

Not yet recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • SBRT alone
  • (no location specified)
Nov 15, 2022

Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy Trial in Chongqing (Super-hyperfractionation Pulse Radiotherapy)

Recruiting
  • Lung Cancer
  • +2 more
  • Super-hyperfractionation Pulse Radiotherapy
  • Chongqing, Chongqing, China
  • +1 more
Feb 22, 2023

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)

Recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • Seoul, Korea, Republic of
  • +1 more
Feb 16, 2023

Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • LDRT+CFRT
  • +2 more
  • Shanghai, China
  • +1 more
Aug 3, 2023

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Basal Cell Carcinoma Trial in Ljubljana (phIL12 GET)

Recruiting
  • Basal Cell Carcinoma
  • phIL12 GET
  • Ljubljana, Slovenia
  • +1 more
Nov 8, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)

Active, not recruiting
  • Mesothelioma; Lung
  • Varying Doses of Background and Boost RT
  • Toronto, Ontario, Canada
    Princess Margaret Hospital, University Health Network
Oct 25, 2022

Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

Recruiting
  • Oncology
  • moderate Whole Body Hyperthermia (mWBH)
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
Apr 6, 2023

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

Recruiting
  • Urinary Bladder Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AtezoBev with combined radiotherapy
  • Seoul, Korea, Republic of
    Severance hospital
Jun 9, 2023

Triple Negative Breast Cancer Trial in Lausanne (stereotactic body radiotherapy, CMP-001)

Recruiting
  • Triple Negative Breast Cancer
  • stereotactic body radiotherapy
  • CMP-001
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jul 6, 2021

Renal Cancer Metastatic Trial in Reggio Emilia (Nivolumab)

Completed
  • Renal Cancer Metastatic
  • Reggio Emilia, Italy
    Struttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Av
May 1, 2022

NSCLC, NSCLC Trial in Switzerland (Durvalumab, Radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • NSCLC
  • Aarau, Switzerland
  • +12 more
Oct 17, 2022

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Solid Tumor, Lymphoma Trial in Beijing (Manganese Chloride, Radiotherapy, Chemo-immunotherapy)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Manganese Chloride
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
May 4, 2021

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022